1/290
Looks like no tags are added yet.
Direct acting poison
A toxic substance acting immediately upon exposure.
Inhalation exposure
Contact with toxicants through the respiratory system.
Grey Baby Syndrome
Condition in infants due to drug metabolism issues.
Geriatric drug toxicity
Increased drug effects due to aging liver function.
Acute exposure toxicity
Toxicity level influenced by elimination rate.
Quantal response
All-or-none response to varying doses.
ED50
Dose producing therapeutic effect in 50% subjects.
Dose-response curve
Graph showing relationship between dose and effect.
Margin of safety (MOS)
Ratio of toxic dose to effective dose.
Potentiation
One drug enhances the effect of another.
Chemical antagonism
Two chemicals produce opposing physiological effects.
Dispositional antagonism
Reduction of toxicant availability in the body.
Allergic reactions
Immune response requiring prior exposure to allergens.
Idiosyncratic reaction
Unusual response to a drug due to genetic factors.
Delayed toxicity
Toxic effects appearing long after exposure.
Reversible toxic effect
Toxic damage that can be repaired.
Systemic toxicity
Toxic effects affecting multiple organ systems.
Toxicology lab
Facility for analyzing toxic substances in samples.
Quantitative test
Test measuring specific concentration of substances.
LD50
Dose lethal to 50% of subjects.
Immunotoxicity assessment
Evaluation of immune system effects from toxins.
AMES test
Test assessing mutagenic potential of substances.
Weak acid absorption
Absorbed better in non-ionized form.
Facilitated diffusion
Transport process requiring a carrier protein.
Volume of distribution
Measure of drug distribution in body compartments.
Biotransformation
Chemical alteration of substances by the body.
Glucuronidation
Phase 2 reaction making compounds more water soluble.
CYP450 enzymes
Enzymes involved in drug metabolism.
Factors affecting biotransformation
Gender, age, diet, and genetics influence metabolism.
Rifampicin interaction
May reduce effectiveness of steroid contraceptives.
CYP3A4
An enzyme that metabolizes steroidal contraceptives.
Rifampicin
An antibiotic that induces CYP3A4 activity.
Contraceptive failure
Ineffective birth control due to drug interactions.
Toxicant elimination routes
Sweat, gastrointestinal tract, renal, and milk.
Weak base toxicant
Absorbed in duodenum, eliminated by urine alkalinization.
Duration of action
Time drug remains effective above minimum concentration.
Pinocytosis
Cellular process involving membrane invagination.
Chromatography
Technique separating analytes based on solid phase interaction.
Efficacy
Drug's effectiveness across a population.
Tolerance
Decreased response to a drug after repeated use.
Adipose tissue
Storage site for lipophilic agents in the body.
Acute exposure
Short-term contact with a toxic agent.
Chronic exposure
Long-term contact with a toxic agent.
Quantal dose-response curve
Describes population response to varying drug doses.
Threshold
Dose level where toxic effects begin to appear.
Therapeutic index
Ratio indicating drug safety margin.
Synergism
Combined effect of drugs exceeds individual effects.
Activated charcoal
Used to prevent absorption of toxicants.
Xenobiotic metabolism
Biotransformation making compounds more water-soluble.
Phase 1 reaction
Initial metabolic process modifying xenobiotics.
Intoxication
Toxic effects resulting from substance exposure.
NSAIDs
Non-steroidal anti-inflammatory drugs, inhibit COX enzymes.
Dextromethorphan
Cough suppressant that can cause hallucinations.
Serotonin syndrome
Toxic reaction from excessive serotonin levels.
Cyclopeptides
Toxins found in mushrooms, can be lethal.
Alkali ingestion
Causes coagulation necrosis and corneal damage.
Diaphoresis
A condition of excessive sweating.
Sympathomimetic
A toxidrome characterized by increased blood pressure, clonus, tremor, and seizures.
Sodium bicarbonate
The best therapeutic for salicylate and cyclic antidepressant overdose.
Opioids
A toxidrome that includes CNS depression, respiratory depression, and mydriasis.
Thalidomide
A drug found to be teratogenic, previously used as a sedative/hypnotic.
Cholinergic
A toxidrome characterized by salivation, lacrimation, and gastrointestinal distress.
Emesis
A method used to prevent absorption of known poisons that are not strong acids/bases.
Diluted acid exposure
Requires therapeutic management to neutralize the acid.
Chloramine
A product formed by mixing bleach and ammonia.
Chlorine gas
A product formed by mixing bleach and acid.
Miosis
A prominent symptom of opioid exposure.
Teratogens
Substances involved in adverse developmental effects during pregnancy.
Dimercaprol
A therapeutic used for indications involving gold, mercury, lead, and arsenic.
Strychnine
An agent that binds glycine receptors causing excitation of the brainstem and spinal cord.
DEET
A product developed by the US Army for jungle warfare to repel insects.
Vitamin K1
The best therapeutic for warfarin and rodenticide anticoagulant exposure.
Calcium channel blockers
A condition that may require therapeutic management for hyperglycemia.
Withdrawal from opioids
A toxidrome characterized by normal mental status with vomiting, diarrhea, and yawning.
Cyclic antidepressants
A class of drugs that can lead to overdose requiring sodium bicarbonate.
Seizures
A prominent symptom from exposure to certain toxic substances.
Agitation
A symptom that may present in patients under the influence of anticholinergics.
Salivation
A symptom associated with cholinergic toxidrome.
Withdrawal ethanol or sedative hypnotics
A toxidrome characterized by increased respiration, temperature, and pupil size.
Sodium channel blockers
A class of drugs that may require therapeutic intervention in overdose cases.
Uridine triacetate
A therapeutic option for certain toxic exposures.
Cholinergic toxidrome
Characterized by symptoms such as salivation and gastrointestinal distress.
CNS depression
A symptom commonly associated with opiate toxidrome.
Sodium hypochlorite
Chemical used for disinfection and bleaching.
Bradydysrhythmias
Abnormally slow heart rhythm requiring treatment.
Physostigmine
Antidote for anticholinergic toxicity.
Calcium gluconate
Used for hydrofluoric acid and calcium channel blocker toxicity.
Pralidoxime
Reactivates acetylcholinesterase in organophosphate poisoning.
Toxicant removal goals
Reduce concentration and combat toxic effects.
Organochlorines
Pesticides including sarin and parathion.
Boxed warning
FDA's strictest warning for drug safety issues.
FDA Pregnancy Category X
Drugs shown to cause fetal abnormalities.
The Joint Commission
Establishes accreditation standards for healthcare quality.
Krokodil
Desomorphine derivative causing severe health issues.
Second generation H1 blockers
Antihistamines with fewer sedative effects.
Amofostine
Antidote for platinum compound toxicity.
CYP2D6
Enzyme metabolizing morphine for analgesia.
N-acetylcysteine
Antidote for acetaminophen overdose.
Delayed hypersensitivity reaction
Allergic reaction occurring 72 hours post-exposure.
ASHP role in emergency preparedness
Involves pharmaceutical selection and patient education.